OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
34
Results
Show all
Save search
Copy query
Show results for
Unknown
(34)
Publication Date
Release Date
2021
(9)
2023
(6)
2024
(4)
2022
(3)
2016
(3)
2020
(2)
2011
(2)
2019
(1)
2018
(1)
2013
(1)
2012
(1)
2008
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
The recurrent deep intronic pseudoexon-inducing variant
COL6A1
c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.
Not available
S-EPMC10996746
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
The retrospective analysis of Antarctic tracking data project.
Not available
S-EPMC7080749
|
biostudies-literature
Cite
Simvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839
|
biostudies-literature
Cite
Biodiversity impacts of the 2019-2020 Australian megafires.
Not available
S-EPMC11602714
|
biostudies-literature
Cite
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.
Not available
S-EPMC4908819
|
biostudies-literature
Cite
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
Not available
S-EPMC4908812
|
biostudies-literature
Cite
The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement.
Not available
S-EPMC9996687
|
biostudies-literature
Cite
Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
Not available
S-EPMC7953587
|
biostudies-literature
Cite
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
Not available
S-EPMC4908820
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets